Washington Trust Bank continued to hold its position in Nu Skin Enterprises, Inc. (NYSE:NUS) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,000 shares of the company’s stock at the end of the second quarter. Washington Trust Bank’s holdings in Nu Skin Enterprises were worth $126,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Creative Planning raised its position in Nu Skin Enterprises by 38.5% in the first quarter. Creative Planning now owns 1,800 shares of the company’s stock worth $100,000 after buying an additional 500 shares during the period. US Bancorp DE raised its position in Nu Skin Enterprises by 3.3% in the second quarter. US Bancorp DE now owns 2,032 shares of the company’s stock worth $128,000 after buying an additional 65 shares during the period. TrimTabs Asset Management LLC raised its position in Nu Skin Enterprises by 88.7% in the first quarter. TrimTabs Asset Management LLC now owns 2,349 shares of the company’s stock worth $130,000 after buying an additional 1,104 shares during the period. Independent Portfolio Consultants Inc. raised its position in Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock worth $132,000 after buying an additional 40 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in Nu Skin Enterprises by 23.0% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,506 shares of the company’s stock worth $139,000 after buying an additional 468 shares during the period. Hedge funds and other institutional investors own 84.53% of the company’s stock.
Nu Skin Enterprises, Inc. (NYSE:NUS) traded up 3.16% during mid-day trading on Friday, hitting $55.48. The stock had a trading volume of 995,807 shares. The company has a 50 day moving average price of $61.67 and a 200 day moving average price of $56.55. The stock has a market cap of $2.94 billion, a P/E ratio of 18.56 and a beta of 1.31. Nu Skin Enterprises, Inc. has a one year low of $46.35 and a one year high of $66.04.
Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.08. The business had revenue of $550.10 million for the quarter, compared to analyst estimates of $548.09 million. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The company’s revenue for the quarter was down 8.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.79 EPS. On average, equities analysts anticipate that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Friday, August 25th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Wednesday, August 23rd. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.60%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 48.81%.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by BNB Daily and is owned by of BNB Daily. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.baseball-news-blog.com/2017/08/19/nu-skin-enterprises-inc-nus-position-maintained-by-washington-trust-bank-updated-updated-updated.html.
A number of research firms recently issued reports on NUS. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Wednesday, August 2nd. Bank of America Corporation lifted their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a report on Monday, July 10th. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Finally, Pivotal Research restated a “buy” rating and issued a $65.00 price target on shares of Nu Skin Enterprises in a research note on Thursday, May 4th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company’s stock. Nu Skin Enterprises has an average rating of “Hold” and an average target price of $62.88.
In other news, General Counsel D Matthew Dorny sold 8,000 shares of the company’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $56.39, for a total value of $451,120.00. Following the sale, the general counsel now owns 52,730 shares in the company, valued at approximately $2,973,444.70. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In the last 90 days, insiders sold 31,750 shares of company stock worth $1,946,810. Company insiders own 5.20% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.